Literature DB >> 7493663

The incidence of rubella virus infections in Switzerland after the introduction of the MMR mass vaccination programme.

L Matter1, F Bally, D Germann, K Schopfer.   

Abstract

We have collected data on the incidence of rubella in Switzerland from 1987 to 1992 to help evaluating the impact of the measles, mumps and rubella (MMR) mass vaccination programme which started in 1985 in this country. We used detailed informations on samples submitted for diagnostic testing in conjunction with anonymous laboratory notifications to the Swiss Federal Office for Public Health, and data from the Swiss sentinel network of general practitioners to find trends in the incidence of rubella after the introduction of mass vaccination. We observed an unabated seasonal oscillation without decreasing trend during the observation period and were unable to detect a shift in the age distribution of cases. An important proportion of laboratory-confirmed rubella occurred in women of childbearing age. Immigrants from regions with low endemicity of rubella were at increased risk of contracting rubella and transmitting it to their offspring. We conclude, that MMR mass vaccination has not interrupted the circulation of rubella virus in Switzerland, and that improvements in the implementation and surveillance of the MMR vaccination campaign are necessary in order to avoid untoward effects of it.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7493663     DOI: 10.1007/bf01719435

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  27 in total

Review 1.  Rubella in the developing world.

Authors:  C L Miller
Journal:  Epidemiol Infect       Date:  1991-08       Impact factor: 2.451

Review 2.  Rubella in the United Kingdom.

Authors:  E Miller
Journal:  Epidemiol Infect       Date:  1991-08       Impact factor: 2.451

3.  Serological evidence of reinfection among vaccinees during rubella outbreak.

Authors:  M G Cusi; G M Rossolini; P E Valensin; C Cellesi; A Zanchi
Journal:  Lancet       Date:  1990-10-27       Impact factor: 79.321

4.  Rubella and congenital rubella syndrome--United States, 1984-1985.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1986-03-07       Impact factor: 17.586

5.  [New Swiss vaccination schedule].

Authors:  M Just
Journal:  Ther Umsch       Date:  1986-07

6.  Changes in the significance of maternal rubella as a factor in childhood deafness--1954 to 1982.

Authors:  L J Upfold
Journal:  Med J Aust       Date:  1984-05-26       Impact factor: 7.738

7.  Rubella surveillance to December 1992: second joint report from the PHLS and National Congenital Rubella Surveillance Programme.

Authors:  E Miller; P A Waight; J E Vurdien; G Jones; P A Tookey; C S Peckham
Journal:  Commun Dis Rep CDR Rev       Date:  1993-02-26

8.  Increase in rubella and congenital rubella syndrome--United States, 1988-1990.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1991-02-15       Impact factor: 17.586

9.  Rubella epidemiology in South East England.

Authors:  D J Nokes; R M Anderson; M J Anderson
Journal:  J Hyg (Lond)       Date:  1986-04

10.  Rubella immunity and morbidity: effects of vaccination in Finland.

Authors:  P Ukkonen; C H von Bonsdorff
Journal:  Scand J Infect Dis       Date:  1988
View more
  7 in total

1.  Antenatal screening for rubella-infection or immunity?

Authors:  Nilesh M Mehta; Roslyn M Thomas
Journal:  BMJ       Date:  2002-07-13

2.  Age-stratified seroprevalence of measles, mumps and rubella (MMR) virus infections in Switzerland after the introduction of MMR mass vaccination.

Authors:  L Matter; D Germann; F Bally; K Schopfer
Journal:  Eur J Epidemiol       Date:  1997-01       Impact factor: 8.082

3.  Decay of passively acquired maternal antibodies against measles, mumps, and rubella viruses.

Authors:  C Nicoara; K Zäch; D Trachsel; D Germann; L Matter
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

Review 4.  Vaccines for measles, mumps and rubella in children.

Authors:  Vittorio Demicheli; Alessandro Rivetti; Maria Grazia Debalini; Carlo Di Pietrantonj
Journal:  Cochrane Database Syst Rev       Date:  2012-02-15

Review 5.  Vaccines for measles, mumps, rubella, and varicella in children.

Authors:  Carlo Di Pietrantonj; Alessandro Rivetti; Pasquale Marchione; Maria Grazia Debalini; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2021-11-22

6.  What is regressive autism and why does it occur? Is it the consequence of multi-systemic dysfunction affecting the elimination of heavy metals and the ability to regulate neural temperature?

Authors:  Graham E Ewing
Journal:  N Am J Med Sci       Date:  2009-07

7.  Vaccines for measles, mumps, rubella, and varicella in children.

Authors:  Carlo Di Pietrantonj; Alessandro Rivetti; Pasquale Marchione; Maria Grazia Debalini; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2020-04-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.